Protocol for the Treatment of Prostate Cancer

Dr. Serge Jurasunas

Professor of Naturopathic Oncology

Serge Jurasunas is an internationally well known figure and pioneer in Naturopathic medicine, iridology, nutrition, complementary oncology, and Live Blood Analysis with 50 years of clinical practice and experience in treating chronic and degenerative diseases, cancer and at the same time he developed several innovative therapies. Having studied both conventional oncology and alternative medical science he can offer a better understanding from both sides, their advantages and failures, explaining what we can expect from either perspective.

Over the past decades he directed several clinics treating patients coming from many countries. He has welcomed many doctors and physicians that have come to Portugal to learn about his methods of treating cancer. Todayhe collaborates with oncologists, medical doctors, researchers to join with him and share mutual experiences and for the promulgation of CAM methods both for the public and doctors.

Lectures in Complementary Oncology

The work of Professor Serge Jurasunas is well known around the world after having traveled and lectured in nearly 40 countries on New Avenues in Cancer Treatment, which attracted the interest of several Universities. Professor Jurasunas has been invited by the University of Vilnius (Lithuania) Faculty of Medicine to deliver a seminar on New Treatment in Oncology, with a audience of about 300 doctors, oncologists, and immunologists. This was a rare privilege to introduce alternative cancer treatments along with the presentation of clinical cases to a Faculty of Medicine.

More recently he delivered a lecture on Molecular Marker Diagnosis in Cancer and Therapy at the 2th International Congress on Complementary Oncology, invited by the German Society of Oncology.

The Molecular Basis of Cancer

Serge Jurasunas is now deeply involved in the research and clinical application of Molecular Markers, tumor suppressor genes and oncogenes associated with cancer initiation, promotion and cancer development, having devoted nearly a decade in study and the practical clinical applications of molecular markers testing with cancer patients before and after treatment, with a follow up over period extending up to 4 years. It permitted a better understanding of the mechanism of genes in cancer. Thisallowed him to check on resistant cancer cells, to make a prognosis for each patient and to select dietary agents and other anticancer agents according to the individual result of each patient. This is the great advantage of personalized medicine that seemed to be a response to cancer treatment, since no two patients have the same tumor suppressor and oncogene activity and therefore may have good or poor result with chemotherapy\radiation.

Publication of a Document on Molecular Markers

Professor Serge Jurasunas, a frequent contributor to Townsend Letter (The Journal of Alternative Medicine (USA), has written articles on cancer disease with clinical cases utilizing molecular markers. The last article is about the Molecular basis of prostate cancer and therapies which is available under request. A new document called, Integrative Cancer-New Theories and Advances in Treatment is now available on Slideshare: http://www.slideshare.net/SheldonStein/integrative-cancer-new-theories-and-advances-in-treatment-from-hippocrates-to-the-human-genome . The article offers a wide array of details about prostate cancer and the involvement of tumor suppressor genes and oncogenes , offering complete details about the effect of each anticancer agent or dietary agent. He both documents and explains what a patient can really expect from conventional medicine, surgery, chemotherapy, radiation, hormonotherapy. He also offers additional details on patient expectations his protocols on prostate cancer, refined over the years that

has demonstrated efficacy at his clinic, even with advanced prostate cancerwith bone metastases.

Prostate Cancer

Prostate cancer has become the #1 killer in men, even now before lung cancer. When a prostate cancer is initially diagnosed, in about 50% of these cases it can be expected that the disease will progress to an incurable stage. However it is true that most prostate cancers are unsymptomatic andslow growing. However one third of these cases are more aggressive and fast developing. Prostate metastases spreads relatively quickly to other parts of the body, particularly lymph nodes, rectum, bones, and the brain. Hypoxia occurs in 30% or 40% of prostate cancers which in turn increase angiogenic factors and upregulate the P53 tumor suppressor gene that triggers apoptosis or the death of cancer cells.

Conventional treatments include a combination of surgery, chemotherapy, radiation and hormonotherapy that may be effective for localizing disease but there currently is no effective treatment strategy for metastasized prostate cancer which remains painful and incurable. Despite advances in local treatment, approximately 25% of radically treated patients will develop disease progression. Presently in 10% to 20% of these cases with a primary diagnostic with bone metastases, chemotherapy could only extend the lives of these patients by months or few years at most.

Metastatic Prostate Cancer with Bone Metastases

One year survival: 87%

Five year survival: 56%

Metastatic Prostate Cancer with Bone and Skeletal Involvement

One year survival: 40%

Five year survival: <1%

What can be Done to Improve this Situation

Therefore prostate cancer must be treated immediately in the beginning with a complementary approach to avoid the spread of metastases in the body. Many cases are hormone refractory, meaning they don't respond any more to hormonal therapy and often not to chemotherapy or radiation leaving the patient without any solution. Secondly advanced prostate cancer with bone and skeleton metastases does not receive any further benefit from chemotherapy requiring some alternative solution. As explained in my document, Integrative Cancer-New Theories and Advances in Treatment, more chemotherapy renders cancer cells more resistant to destruction by apoptosis and contributes to making the disease worse, further weakening the patient.

Testing Cancer Cells for Genetic Markers

In our clinic cancer cells are tested for genetic markers such as the P53 tumor suppressor gene, Bax, BcL2,survivin, P21, VEGF and others. Some oncogenes and inhibitors of apoptosis such as BcL2 and survivin are usually overexpressed in prostate cancer increasing cancer cell resistance. Such testing allows for individual and personalized treatment based upon test results and using selected dietary agents, phytotherapy, orthomolecularmedicine and other anticancer agents appropriate to treating the prostate cancer cells that in turn increase apoptosis, inhibit angiogenesis, increase immune defense and reduce tumor growth. Thanks to the research done by Prof. Serge Jurasunas who spent considerable time in scientific investigation and work, and even developed new formulas in his own pharmaceutical laboratory.

Serge Jurasunas's Natural Medicine

During the past five decades Serge Jurasunas has accumulated ample clinical experience and knowledge by working with over 150,000 patients having utilized all kinds of diets and therapies from different sources to build his unique Natural Medicine Therapy. Focusing on cancer treatment, the methods of Professor Serge Jurasunas have created a bridge between

Naturopathic medicine and Molecular medicine, which permits us to treat the disease and the whole body simultaneously. We know that natural food can change genetic expression and many dietary agents such as curcumin can target several mechanisms associated with cancer development and growth.

Over the past 50 years Serge Jurasunas has experimented with a number ofdietary agents to see how they can modify tumor suppressor genes and oncogenes after molecular markers testing. After several years of observation with several hundred cancer cases he began to select some dietary agents and other anticancer compounds that work in synergy and offer better results in targeting cancer, often leading patients to a complete remission or an extended lifespan even when the disease is far advanced.

In our clinic we handle all types and grades of cancer including prostate cancer even the most advanced cases with bone and skeleton metastases, from low to high PSA levels that can be over 1200 ul\ml. For example we had a case of a 73 year old man diagnosed in September 2005 with metastasized prostate cancer that was disseminated all over the skeleton. InMay, 2006 he came to me in very bad physical condition. PSA at 1260, no surgery, chemotherapy or radiation was suggested by doctors. Only a hormonal therapy but without visible result. After 4 months of our treatment the patient considerably improved physically and felt happy. PSA decreased to 328 and after 8 months to 58 and finally to 2.8 and 1.58 after one year. After 6 months 50% of the bone metastases was eliminated and after one year, total elimination. The patient is in remission with a good quality of life. Other cases are available at www.sergejurasunas.com, include a taxi driver, who also had advanced prostate cancer, who with no conventional treatment was cured after one year. He remained free from allthe skeletal metastases where we followed him for over 10 years.

New Protocol for Prostate Cancer Recently Serge Jurasunas has discovered a new treatment for prostate cancer by including new anticancer agents that he had developed over a period of 2 years. Remarkable results were obtained with Molecular Markers Testing. Patients were taking this treatment found its efficacy decreased high levels of PSA and reduced or eliminated tumors and bone metastases. Other anti-cancer compounds are now in use with a success

record of over 2 decades, such the Arabynoxylan compound Biobran alongwith other protocols used for other types of cancer. Many results of these clinical cases have been published in the Townsend Letter the Journal of Alternative Medicine (USA).

How to Approach Prostate Cancer

Cancer must be approached in several directions at same time that includethe following process which is considered by some as an important Hallmark of Cancer Treatment.

1. Apoptosis (killing of own cancer cells)2. Angiogenesis (VEGF, FGF)3. Tumor suppressor (TGFB, cMyc, P53)4. Oncogenes (BcL2 Survivin)5. Inflammation (NF Kappa B, Cox2)6. Immune modulation (NK cells dendritic cells, T cells, B cells,

Macrophages)

Other factors can include blood parameters such anemia, candida growth, balancing the microbiome and strengthening the nervous system since their is a relationship between the nervous system and the activation of the Natural Killer Cells (N.K.Cells).

Suggested Protocol

This protocol is adapted to respond to the Six Hallmarks of Cancer and has shown efficiency to target the oncogene BcL2 and the inhibitor of apoptosis survivin both overexpressed in prostate cancer and responsible for cancer cells resistance to chemotherapy and radiation.

Tegaran is made from fermented soy that contains phytic acid, protease inhibitors, saponins, phytosterols and genistein. All in vitro and in vivo tests and clinical studies have confirmed the positive effects of the ingredients of the fermented soy extract in therapeutic approaches for adjuvant treatment of solid tumors. Tegaran targets most of the molecular aspects of cancer development and growth including apoptosis, angiogenesis, immune system, inflammation and drug resistance.

Curcumin is an important dietary agent that acts on blocking the different stages of cancer and inhibits malignant cell proliferation during the growthand progression of prostate cancer. Curcumin acts on most of the genes implicated in cancer. In prostate cancer curcumin has shown efficacy to increase the destruction of cancer cells by halting the cell cycle phase at G2 or M and sensitizes tumor cells to various antineoplasic agents.

Furthermore, curcumin targets the oncogene BcL2 and survivin and increases P53 function therefore triggering apoptosis and decreasing the resistance of cancer cells to chemotherapy and radiation. Importantly curcumin inhibits the NF Kappa B, an inflammatory mediator that stimulates most of the mechanisms associated with tumor growth, progression and resistance to anticancer drugs.

Biobran (Biological Response Modifier)

We have used Biobran for over 2 decades being an important immunomodulator with anticancer properties. Biobran is a arabinoxylan compound extracted out of rice bran cultivated on shitake enzyme and has shown to have dramatic effects on our front line soldiers in the immune system that work against cancer. It includes NK cells, dendritic cells and macrophages. NK cells play an important function in the primary host defense against cancer where defective NK cell function is associated withvarious malignancies. Most cancer patients have a defective immune system functioning from 0% to 30% compared to a healthy person. The NK cells are present but not activated to release their toxic enzymes to destroy cancer cells through N.K. apoptosis. N.K. cell activity is increasedby 60% after 2 weeks with a daily dose of 2gr. of Biobran, but if you continue you can achieve up to a 200% and 300% increase of NK cell number and activity. Biobran has demonstrated efficacy to kill cancer cellseither by apoptosis or lysis and has a dramatic effect on prostate cancer especially when prescribed in synergy with curcumin. Biobran Mgn3 is much more powerful that other arabynoxylan and extract of mushroom found on the market.

Prae Cell Formulation

This is a formula especially developed for prostate cancer that contains fermented soy (same formula as Tegaran), lycopene from tomatoes, zinc,

selenium and vitamin D3, particularly efficient in treating prostate cancer.

Detoxification

Detoxification is one important step in treating any disease especially cancer. Most peoples are intoxicated from bad dietary style, excess of food, constipation and by an excess of industrial foods that produce endogenous toxins. These exogenous toxins also come from the environment. We found 700 chemicals in drinking water, 3000 chemicals in food and 10,000 chemicals in food processing, fertilizers and pesticides the use which continues to increase. Colon intoxication from constipation especially in case of prostate cancer cannot be minimized. According to Oncologist, Dr. Joseph Brenner not only do people already have an excess of toxins when cancer is diagnosed, but the amount of toxins increases due to the intake of toxic drugs and the breakdown of tumors that poison the body, damage the liver and interfere with our immune defense which then becomes weaker.

Therefore Dr. Brenner suggests, as I have for so many years implementing colon cleansing, diet and mini fasting. You can also learn more by readingmy new book, Health and Disease Begin in the Colon - Featuring Professor Serge Jurasunas Natural Medicine, a 350 page book with over 100 figures and color photographs wit special chapters about how to detox, beneficial healing food, healthy diet, some important supplements, auto-intoxication of the colon and dramatic clinical cases. (Available on Amazon or from the Author at: www.sergejurasunas.com )

Active Detox

To activate detoxification and reinforce treatment there is a excellent formula made of coriander, chlorella cell peptide, spinach, green tea, extract of rosemary, brassica (from broccoli), n-acetyl cystein, methionine, zinc and selenium which are also important for prostate cancer.

Case of Earlier Prostate Cancer (or hypertrophy, higher PSA level)Prae cell, Curcumin, Biobran, Active Detox

Case of Prostate Cancer with Bone Metastases, Advanced DiseaseTreatment : Tegaran, Curcumin, Biobran, Prae cell, Active Detox

However even with local prostate cancer a patient can take Tegaran if the PSA is still increasing. Often the advice of a physician is required and we invite patients to come to our clinic for consultation. If not they can have a consultation by phone, email, Skype for a personalized treatment, diet, or nutritional advice. To learn more about prostate cancer read the new articlepublished in Townsend Letter the Journal of Alternative Medicine(USA) orcontact Dr. Jurasunas directly. The Molecular basis of Prostate Cancer article can offer more information about treatment to be published in the special cancer issue of the Townsend Letter ( August\Sept 2017).

Contact Information:

phone: 351 912565038

email: sergejurasunas@hotmail.com

Skype: serge jurasunas